Hemophagocytic syndrome after autologous peripheral blood stem cell transplantation for multiple myeloma: Successful treatment with high-dose intravenous immunoglobulin [6]

Bone Marrow Transplantation

Volumn 37, Issue 8, 2006, Pages 797-798

  Ostronoff, M ^a   Ostronoff, F ^a   Coutinho, M ^a   Calixto, R ^a   Souto Maior, A P ^a   Sucupira, A ^a   Florencio, R ^a   Tagliari, C ^a  

^a Real Hospital Portugues   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; AMPHOTERICIN B; CEFEPIME; DEXAMETHASONE; DOXORUBICIN; GAMMA INTERFERON; GRANULOCYTE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN; INTERLEUKIN 6; MELPHALAN; TUMOR NECROSIS FACTOR ALPHA; VANCOMYCIN; VINCRISTINE;

ADULT; APLASIA; AUTOLOGOUS PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; BONE MARROW BIOPSY; CASE REPORT; CYTOKINE RELEASE; DRUG EFFICACY; DRUG MEGADOSE; EFFECTOR CELL; ERYTHROCYTE TRANSFUSION; ERYTHROPHAGOCYTOSIS; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEMOPHAGOCYTIC SYNDROME; HUMAN; HYPOVOLEMIC SHOCK; IMMUNOSUPPRESSIVE TREATMENT; LETTER; MULTIPLE MYELOMA; PATHOGENESIS; PRIORITY JOURNAL; PYREXIA IDIOPATHICA; T LYMPHOCYTE ACTIVATION; THROMBOCYTE TRANSFUSION;

CYTOKINES; FEMALE; HUMANS; IMMUNE SYSTEM; IMMUNOGLOBULINS, INTRAVENOUS; LYMPHOHISTIOCYTOSIS, HEMOPHAGOCYTIC; MIDDLE AGED; MULTIPLE MYELOMA; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PHAGOCYTOSIS; TIME FACTORS; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME;

EID: 33645702794     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/sj.bmt.1705329     Document Type: Letter

References (10)

1. Henter JI, Elinder G, Ost A. Diagnostic guidelines for hemophagocytic lymphohistiocytosis. The FHL Study Group of the Histiocyte Society. Semin Oncol 1991; 18: 29-33.
2. Stepp SE, Dufourcq-Lagelouse R, Le Deist F, Bhawan S, Certain S, Mathew PA et al. Perforin gene defects in familial hemophagocytic lymphohistiocytosis. Science 1999; 286: 1957-1959.
3. Janka G, Imashuku S, Elinder G, Schneider M, Henter JI. Infection- and malignancy-associated hemophagocytic syndromes. Secondary hemophagocytic lymphohistiocytosis. Hematol Oncol Clin N Am 1998; 12: 435-444.
4. Ravelli A. Macrophage activation syndrome. Curr Opin Rheumatol 2002; 14: 548-552.
5. Henter JI, Elinder G, Soder O, Hansson M, Andersson B, Andersson U. Hypercytokinemia in familial hemophagocytic lymphohistiocytosis. Blood 1991; 78: 2918-2922.
6. Larroche C, Bruneel F, Andre MH, Bader-Meunier B, Baruchel A, Tribout B, et al., Comite d'Evaluation et de Diffusion des Innovation Technologiques (CEDIT). Intravenously administered gamma-globulins in reactive hemaphagocytic syndrome. Multicenter study to assess their importance, by the immunoglobulins group of experts of CEDIT of the AP-HP. Ann Med Interne (Paris) 2000; 151: 533-539.
7. Billiau AD, Roskams T, Van Damme-Lombaerts R, Matthys P, Wouters C. Macrophage activation syndrome: Characteristic findings on liver biopsy illustrating the key role of activated, IFN-gamma-producing lymphocytes and IL-6- and TNF-alpha-producing macrophages. Blood 2005; 105: 1648-1651 (E-pub 2004 Oct 5).
8. Singh RK, Ino K, Varney ML, Heimann DG, Talmadge JE. Immunoregulatory cytokines in bone marrow and peripheral blood stem cell products. Bone Marrow Transplant 1999; 23: 53-62.
9. Pradalier A, Teillet F, Molitor JL, Drappier JC. Macrophage activation syndrome, hemophagocytic syndrome. Pathol Biol (Paris) 2004; 52: 407-414.
10. Fujiwara F, Hibi S, Imashuku S. Hypercytokinemia in hemophagocytic syndrome. Am J Pediatr Hematol Oncol 1993; 15: 92-98.